Manufacturer
Titlis Pharma (Private) Limited 44
Every registration held by this company that appears in the DRAP price index. Categories on record: Essential Drugs, Low Price Drugs.
- Registrations
- 44
- Categories
- 2
- Pack sizes on record
- 60
Registrations
| Registered name | Reg. No. | Category | Packs |
|---|---|---|---|
| Azipos 200mg/5ml Dry Powder Suspension | 115425 | Essential Drugs | 1 |
| Azipos 500mg Tablet | 102618 | Essential Drugs | 1 |
| Azipos Capsule 250mg | 078812 | Essential Drugs | 1 |
| Carbatit 200mg Tablet | 119316 | Essential Drugs | 2 |
| Ciprolis 125mg/5ml Dry Suspension | 116676 | Essential Drugs | 1 |
| Ciprolis 250mg Tablets | 085179 | Essential Drugs | 1 |
| Ciprolis 250mg/5ml Dry Suspension | 116677 | Essential Drugs | 1 |
| Ciprolis Tablets 500mg | 078821 | Essential Drugs | 1 |
| Conazit Capsule 150mg | 078813 | Essential Drugs | 2 |
| Dapatit 10mg Tablet | 115201 | Essential Drugs | 2 |
| Dapatit 5mg Tablet | 115200 | Essential Drugs | 2 |
| GerEpo 2000IU Injection | 084786 | Essential Drugs | 1 |
| GerEpo 2000IU Pre-Filled Syringe | 084790 | Essential Drugs | 1 |
| GerEpo 3000IU Injection | 084787 | Essential Drugs | 1 |
| GerEpo 3000IU Pre-filled Syringe | 084791 | Essential Drugs | 1 |
| GerEpo 4000IU Injection | 084788 | Essential Drugs | 1 |
| GerEpo 4000IU Pre-filled Syringe | 084792 | Essential Drugs | 2 |
| GerEpo 5000IU Injection | 084789 | Essential Drugs | 1 |
| Ibulis 100mg Liquid Suspension | 078815 | Essential Drugs | 2 |
| Ibulis 200mg Liquid Suspension | 078814 | Essential Drugs | 1 |
| Irobest Syrup | 078816 | Essential Drugs | 2 |
| Irobest-F Tablet | 085840 | Essential Drugs | 3 |
| Irotit 100mg/5ml Syrup | 110606 | Essential Drugs | 1 |
| Irotit 150mg Capsules | 110607 | Essential Drugs | 1 |
| Levolis 250mg Tablets | 085178 | Essential Drugs | 1 |
| Levolis Tablets 500mg | 078820 | Essential Drugs | 1 |
| Lisformin Tablets 500mg | 078823 | Low Price Drugs | 1 |
| Lopilis Tablet 200/50mg | 106020 | Essential Drugs | 1 |
| LVT 250mg Tablet | 102616 | Essential Drugs | 2 |
| LVT 500mg Tablet | 102617 | Essential Drugs | 2 |
| Metrolis Oral Suspension | 078818 | Essential Drugs | 3 |
| Moxilis Tablets 400mg | 078824 | Essential Drugs | 1 |
| Omsta 40mg Capsule | 097530 | Essential Drugs | 1 |
| Omsta Capsule 20mg | 078871 | Essential Drugs | 1 |
| ORS Sachet | 121493 | Essential Drugs | 1 |
| Oselvir 75mg capsule | 106021 | Essential Drugs | 1 |
| Respiklar 125mg/5ml Suspension | 116459 | Essential Drugs | 1 |
| Respiklar 250mg Tablets | 093552 | Essential Drugs | 1 |
| Respiklar 250mg/5ml Suspension | 116460 | Essential Drugs | 1 |
| Respiklar 500mg Tablets | 093553 | Essential Drugs | 1 |
| Roxalis 10mg Tablet | 105897 | Essential Drugs | 1 |
| Roxalis 15mg Tablet | 105898 | Essential Drugs | 2 |
| Roxalis 2.5mg Tablet | 105896 | Essential Drugs | 2 |
| Roxalis 20mg Tablet | 105899 | Essential Drugs | 2 |
How this list is built
The DRAP register records a marketing-authorisation holder per product but has no company index, so this page is assembled from the manufacturer named on each product’s row in the DRAP price index. It therefore covers the 44 registrations of this company that have an approved price on record — not necessarily everything the company is licensed to make.
Company names appear in the source file in several spellings. They are merged only when the difference is punctuation, legal form or a prefix, so two genuinely different companies sharing a first word stay separate. Where a single registration’s rows name two different companies, it is left off every manufacturer page rather than attributed to one of them.